Sort   by:  
 Page size 
UnknownSAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma.
Not available
S-EPMC9913367 | biostudies-literature
UnknownPrognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort.
Not available
S-EPMC7338015 | biostudies-literature
UnknownAn epigenetic clock for gestational age at birth based on blood methylation data.
Not available
S-EPMC5054584 | biostudies-literature
UnknownMeta-analyses identify DNA methylation associated with kidney function and damage.
Not available
S-EPMC8660832 | biostudies-literature
UnknownMachine learning using the extreme gradient boosting (XGBoost) algorithm predicts 5-day delta of SOFA score at ICU admission in COVID-19 patients.
Not available
S-EPMC8531027 | biostudies-literature
UnknownImplications of early respiratory support strategies on disease progression in critical COVID-19: a matched subanalysis of the prospective RISC-19-ICU cohort.
Not available
S-EPMC8146172 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownPredominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893 | biostudies-literature
UnknownCost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
Not available
S-EPMC9896372 | biostudies-literature
UnknownAflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Not available
S-EPMC9714135 | biostudies-literature
Sort   by:  
 Page size